Osol ed., Remington's Pharmaceutical Sciences, 16th Ed., Mack Publishing Co., Easton, Pa. 1980, pp. 1483-1484. |
Ludwig et al; "Chemical and Biological Stability of Anticancer Drugs Used in a Human Tumor Clonogenic Assay," Cancer Chemother. Pharmacol. 12:142-145 (1984); Chem. Abstr., 101, p. 345, Abstr. No. 116635u (1984). |
Sato et al., "Antitumor Etoposide Injection" (Jp SN 60,239,415); Chem. Abstr., 104, p. 449, Abstr. No. 95509a (1986); only Abstract provided. |
Hamon et al., "Study on the Stability in Dilute Solutions Destined for Perfusion of Two Antimitotics Derived from Podophyllotoxin: Etoposide (VP16) and Teniposide (VN26)," S.T.P. Pharma., 3(1), 33-40 (1987); Chem. Abstr., 107, p. 378, Abstr. No. 83767g (1987); only Abstract provided. |
Tanaka et al., "Stability of Etoposide," Kagaku Ryoho no Ryoiki, 3(9), 1459-1467 (1987); Chem. Abstr., 107, p. 357, Abstr. No. 223147g (1987); only Abstract provided. |
Grant et al. eds., Grant & Hackh's Chemical Dictionary, McGraw-Hill Book Company, New York, 1987, p. 346. |
Seargeant et al., "In Vitro Stability and Compatibility of Daunorubicin, Cytarabine and Etoposide," Cancer Treatment Repts., 71(12):1189-1192; Chem. Abstr., 108, p. 327, Abstr. No. 26897w (1988). |
Shah et al; "Preformulation Study of Etoposide: Identification of Physicochemical Characteristics Responsible for the Low and Erratic Oral Bioavailability of Etoposide," Pharmaceutical Res., 6(5):408-412; Chem. Abstr., 111, p. 385, Abstr. No. 83960x (1989). |
Stewart et al; "Stability of Cisplatin and Epotoside in Intravenous Admixture," Am. J. Hospit. Pharm., 46:1400-1404 (1989); Chem. Abstr., 111, p. 388, Abstr. No. 140313q (1989). |
Aoki et al., "Antitumor Formulations Containing Etoposide," EPO Appl. 401,695; Chem. Abstr., 111, p. 388, Abstr. No. 150207j (1991); only Abstract provided. |
Izawa et al; Chemical Abstracts 114:43481x (1991). |